{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:30:15Z","timestamp":1794000615418,"version":"4.8.0"},"reference-count":45,"publisher":"Japanese Circulation Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,3,25]]},"DOI":"10.1253\/circj.cj-24-0844","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T18:11:37Z","timestamp":1741716697000},"page":"470-478","source":"Crossref","is-referenced-by-count":9,"title":["Establishing Cross-Specialty Expert Consensus on the Optimal Management of Hyperkalemia in Patients With Heart Failure and Chronic Kidney Disease"],"prefix":"10.1253","volume":"89","author":[{"given":"Takeshi","family":"Kitai","sequence":"first","affiliation":[{"name":"Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kuwahara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Shinshu University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[{"name":"Kawasaki Geriatric Medical Center, Kawasaki Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Umebayashi R, Uchida HA, Matsuoka-Uchiyama N, Sugiyama H, Wada J. Prevalence of chronic kidney disease and variation of its risk factors by the regions in Okayama Prefecture. <i>J Pers Med<\/i> 2022; 12: 97.","DOI":"10.3390\/jpm12010097"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zhang L, Ono Y, Qiao Q, Nagai T. Trends in heart failure prevalence in Japan 2014\u20132019: A report from healthcare administration databases. <i>ESC Heart Fail<\/i> 2023; 10: 1996\u20132009.","DOI":"10.1002\/ehf2.14321"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rangaswami J, Bhalla V, Blair JEA, Chang TI, Costa S, Lentine KL, et al. Cardiorenal syndrome: Classification, pathophysiology, diagnosis, and treatment strategies: A Scientific Statement from the American Heart Association. <i>Circulation<\/i> 2019; 139: e840\u2013e878.","DOI":"10.1161\/CIR.0000000000000664"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kanda E, Kashihara N, Kohsaka S, Okami S, Yajima T. Clinical and economic burden of hyperkalemia: A nationwide hospital-based cohort study in Japan. <i>Kidney Med<\/i> 2020; 2: 742\u2013752.e1.","DOI":"10.1016\/j.xkme.2020.09.003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sarnowski A, Gama RM, Dawson A, Mason H, Banerjee D. Hyperkalemia in chronic kidney disease: Links, risks and management. <i>Int J Nephrol Renovasc Dis<\/i> 2022; 15: 215\u2013228.","DOI":"10.2147\/IJNRD.S326464"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kashihara N, Kohsaka S, Kanda E, Okami S, Yajima T. Hyperkalemia in real-world patients under continuous medical care in Japan. <i>Kidney Int Rep<\/i> 2019; 4: 1248\u20131260.","DOI":"10.1016\/j.ekir.2019.05.018"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kuwayama T, Okumura T, Kondo T, Oishi H, Kimura Y, Kazama S, et al. Characteristics, treatment, and prognosis in octogenarian and older patients with acute heart failure in Japan: Prospective Observational Study on Acute Pharmacotherapy and Prognosis in Management of Acute Heart Failure (POPEYE-AHF Registry). <i>Circ J<\/i> 2024; 89: 83\u201392.","DOI":"10.1253\/circj.CJ-24-0299"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Burton JO, Coats AJS, Kovesdy CP, Palmer BF, Pi\u00f1a IL, Rosano G, et al. An international Delphi consensus regarding best practice recommendations for hyperkalaemia across the cardiorenal spectrum. <i>Eur J Heart Fail<\/i> 2022; 24: 1467\u20131477.","DOI":"10.1002\/ejhf.2612"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. <i>Eur Heart J<\/i> 2021; 42: 3599\u20133726.","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 Clinical practice guideline for the evaluation and management of chronic kidney disease. <i>Kidney Int<\/i> 2024; 105: S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kohsaka S, Okami S, Morita N, Yajima T. Risk-benefit balance of renin-angiotensin-aldosterone inhibitor cessation in heart failure patients with hyperkalemia. <i>J Clin Med<\/i> 2022; 11: 5828.","DOI":"10.3390\/jcm11195828"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Morales E, Cravedi P, Manrique J. Management of chronic hyperkalemia in patients with chronic kidney disease: An old problem with news options. <i>Front Med (Lausanne)<\/i> 2021; 8: 653634.","DOI":"10.3389\/fmed.2021.653634"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kanda E, Rastogi A, Murohara T, Les\u00e9n E, Agiro A, Arnold M, et al. Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia. <i>BMC Nephrol<\/i> 2023; 24: 18.","DOI":"10.1186\/s12882-022-03054-5"},{"key":"14","unstructured":"14. Alfonzo A, Harrison A, Baines R, Chu A, Mann S, MacRury M. Renal Association Clinical Practice Guidelines: Treatment of acute hyperkalaemia in adults. UK Kidney Association 2023. https:\/\/www.ukkidney.org\/sites\/default\/files\/FINAL%20VERSION%20-%20UKKA%20CLINICAL%20PRACTICE%20GUIDELINE%20-%20MANAGEMENT%20OF%20HYPERKALAEMIA%20IN%20ADULTS%20-%20191223_0.pdf (accessed February 2025)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sato Y, Kuragaichi T, Nakayama H, Hotta K, Nishimoto Y, Kato T, et al. Developing multidisciplinary management of heart failure in the super-aging society of Japan. <i>Circ J<\/i> 2023; 88: 2\u20139.","DOI":"10.1253\/circj.CJ-22-0675"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kinugasa Y, Saitoh M, Ikegame T, Ikarashi A, Kadota K, Kamiya K, et al. Differences in priorities for heart failure management between cardiologists and general practitioners in Japan. <i>Circ J<\/i> 2021; 85: 1565\u20131574.","DOI":"10.1253\/circj.CJ-21-0335"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Imamura T, Oshima A, Narang N, Kinugawa K. Clinical implications of sodium zirconium cyclosilicate therapy in patients with systolic heart failure and hyperkalemia. <i>J Clin Med<\/i> 2021; 10: 5523.","DOI":"10.3390\/jcm10235523"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kurvers RHJM, Herzog SM, Hertwig R, Krause J, Carney PA, Bogart A, et al. Boosting medical diagnostics by pooling independent judgments. <i>Proc Natl Acad Sci USA<\/i> 2016; 113: 8777\u20138782.","DOI":"10.1073\/pnas.1601827113"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Zhao MH, Chen W, Cheng H, Liu BC, Mao ZG, Tian Z, et al. A Chinese multi-specialty Delphi consensus to optimize RAASi usage and hyperkalaemia management in patients with chronic kidney disease and heart failure. <i>Chin Med Sci J<\/i> 2024; 39: 79\u201390.","DOI":"10.24920\/004327"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Arici M, Assaad-Khalil SH, Bertoluci MC, Choo J, Lee YJ, Madero M, et al. Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): From screening to complications. <i>BMJ Open<\/i> 2024; 14: e080891.","DOI":"10.1136\/bmjopen-2023-080891"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Gattrell WT, Logullo P, van Zuuren EJ, Price A, Hughes EL, Blazey P, et al. ACCORD (ACcurate COnsensus Reporting Document): A reporting guideline for consensus methods in biomedicine developed via a modified Delphi. <i>PLoS Med<\/i> 2024; 21: e1004326.","DOI":"10.1371\/journal.pmed.1004326"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Taylor E. We agree, don\u2019t we?: The Delphi method for health environments research. <i>HERD<\/i> 2020; 13: 11\u201323.","DOI":"10.1177\/1937586719887709"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, et al. Defining consensus: A systematic review recommends methodologic criteria for reporting of Delphi studies. <i>J Clin Epidemiol<\/i> 2014; 67: 401\u2013409.","DOI":"10.1016\/j.jclinepi.2013.12.002"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Matsukawa R, Kabu K, Koga E, Hara A, Kisanuki H, Sada M, et al. Optimizing guideline-directed medical therapy during hospitalization improves prognosis in patients with worsening heart failure requiring readmissions. <i>Circ J<\/i> 2024; 88: 1416\u20131424.","DOI":"10.1253\/circj.CJ-24-0265"},{"key":"25","unstructured":"25. Japanese Society of Nephrology. Clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2024. JSN 2024 (in Japanese)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Yap DYH, Ma RCW, Wong ECK, Tsui MSH, Yu EYT, Yu V, et al. Consensus statement on the management of hyperkalaemia: An Asia-Pacific perspective. <i>Nephrology<\/i> 2024; 29: 311\u2013324.","DOI":"10.1111\/nep.14281"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. De Nicola L, Ferraro PM, Montagnani A, Pontremoli R, Dentali F, Sesti G. Recommendations for the management of hyperkalemia in patients receiving renin-angiotensin-aldosterone system inhibitors. <i>Intern Emerg Med<\/i> 2024; 19: 295\u2013306.","DOI":"10.1007\/s11739-023-03427-0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. MacLaughlin HL, McAuley E, Fry J, Pacheco E, Moran N, Morgan K, et al. Re-thinking hyperkalaemia management in chronic kidney disease: Beyond food tables and nutrition myths: An evidence-based practice review. <i>Nutrients<\/i> 2023; 16: 3.","DOI":"10.3390\/nu16010003"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Borrelli S, Matarazzo I, Lembo E, Peccarino L, Annoiato C, Scognamiglio MR, et al. Chronic hyperkaliemia in chronic kidney disease: An old concern with new answers. <i>Int J Mol Sci<\/i> 2022; 23: 6378.","DOI":"10.3390\/ijms23126378"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Group. KDIGO 2021 Clinical practice guidelines for the management of blood pressure in chronic kidney disease. <i>Kidney Int<\/i> 2021; 99: 1\u201387.","DOI":"10.1016\/j.kint.2020.11.003"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Baker M, Perazella MA. NSAIDs in CKD: Are They Safe? <i>Am J Kidney Dis<\/i> 2020; 76: 546\u2013557.","DOI":"10.1053\/j.ajkd.2020.03.023"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wang AYM. Optimally managing hyperkalemia in patients with cardiorenal syndrome. <i>Nephrol Dial Transplant<\/i> 2019; 34(Suppl): ii36\u2013iii44.","DOI":"10.1093\/ndt\/gfz225"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, et al. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology. <i>Eur Heart J Cardiovasc Pharmacother<\/i> 2018; 4: 180\u2013188.","DOI":"10.1093\/ehjcvp\/pvy015"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Svensson MK, Murohara T, Les\u00e9n E, Arnold M, Cars T, J\u00e4rbrink K, et al. Hyperkalaemia-related reduction of RAASi treatment associates with more subsequent inpatient care. <i>Nephrol Dial Transplant<\/i> 2024; 39: 1258\u20131267.","DOI":"10.1093\/ndt\/gfae016"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Nakayama T, Yamaguchi S, Hayashi K, Uchiyama K, Tajima T, Azegami T, et al. Compared effectiveness of sodium zirconium cyclosilicate and calcium polystyrene sulfonate on hyperkalemia in patients with chronic kidney disease. <i>Front Med (Lausanne)<\/i> 2023; 10: 1137981.","DOI":"10.3389\/fmed.2023.1137981"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Noel JA, Bota SE, Petrcich W, Garg AX, Carrero JJ, Harel Z, et al. Risk of hospitalization for serious adverse gastrointestinal events associated with sodium polystyrene sulfonate use in patients of advanced age. <i>JAMA Intern Med<\/i> 2019; 179: 1025.","DOI":"10.1001\/jamainternmed.2019.0631"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Lu Y, Liu BC, Liu H. An evaluation of sodium zirconium cyclosilicate: A new treatment option for hyperkalaemia in China. <i>Expert Opin Pharmacother<\/i> 2023; 24: 301\u2013308.","DOI":"10.1080\/14656566.2022.2161884"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, et al. JCS\/JHFS 2021 Guideline focused update on diagnosis and treatment of acute and chronic heart failure. <i>Circ J<\/i> 2021; 85: 2252\u20132291.","DOI":"10.1253\/circj.CJ-21-0431"},{"key":"39","unstructured":"39. Expert Group of Chinese Society of Nephrology. Expert consensus on the management of serum potassium in chronic kidney disease patients in China. <i>Chinese Journal of Nephrology<\/i> 2020; 36: 781\u2013792."},{"key":"40","unstructured":"40. Chinese Medical Association Heart Failure Committee, Heart Failure Committee of the National Cardiovascular Disease Expert Committe. Expert consensus on ion management in patients with heart failure in China. <i>Chin J Heart Fail Cardiomyopathy<\/i> 2020; 4: 16\u201331."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Rossignol P, Pitt B. Sodium polystyrene is unsafe and should not be prescribed for the treatment of hyperkalaemia: Primum non nocere! <i>Clin Kidney J<\/i> 2023; 16: 1221\u20131225.","DOI":"10.1093\/ckj\/sfad090"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Onogi C, Watanabe Y, Tanaka A, Furuhashi K, Maruyama S. Mortality and hyperkalaemia-associated hospitalisation in patients with chronic kidney disease: Comparison of sodium zirconium cyclosilicate and sodium\/calcium polystyrene sulfonate. <i>Clin Kidney J<\/i> 2024; 17: sfae021.","DOI":"10.1093\/ckj\/sfae021"},{"key":"43","unstructured":"43. Pickup L, Law JP, Townend JN, Ferro CJ. Cardiorenal medicine: An emerging new speciality or a need for closer collaboration? <i>Br J Cardiol<\/i> 2020; 27: 77\u201378."},{"key":"44","unstructured":"44. Sankaranarayanan R, Douglas H, Wong C. Cardio-nephrology MDT meetings play an important role in the management of cardiorenal syndrome. <i>Br J Cardiol<\/i> 2020; 27: 26."},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. de la Espriella R, Marcos MC, Ronco C, Banerjee D, Gonz\u00e1lez M, G\u00f3rriz JL, et al. Practical approaches to building up a cardiorenal clinic. <i>Clin Kidney J<\/i> 2023; 16: 780\u2013792.","DOI":"10.1093\/ckj\/sfac258"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/4\/89_CJ-24-0844\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:16:54Z","timestamp":1761362214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/89\/4\/89_CJ-24-0844\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0844","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"article-number":"CJ-24-0844"}}